Meyka Pro banner
Ainos, Inc.

Ainos, Inc. Fundamental Analysis (NASDAQ: AIMD)

AIMD●NASDAQ
HealthcareBiotechnology
$1.04
$0.57(121.61%)
U.S. Market is Open · 14:00

Ainos, Inc. Fundamental Analysis (NASDAQ: AIMD)

Ainos, Inc. (NASDAQ: AIMD) shows moderate financial fundamentals with a PE ratio of -0.18, profit margin of -1062.83%, and ROE of -2.17%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 4.99%.

Key Strengths

Cash Position39.98%
PEG Ratio-0.00

Areas of Concern

ROE-2.17%
Operating Margin-1012.10%
Current Ratio0.13
We analyze AIMD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -79925.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-79925.2/100

We analyze AIMD's fundamental strength across five key dimensions:

Efficiency Score

Weak

AIMD struggles to generate sufficient returns from assets.

ROA > 10%
-73.89%

Valuation Score

Excellent

AIMD trades at attractive valuation levels.

PE < 25
-0.18
PEG Ratio < 2
-0.00

Growth Score

Weak

AIMD faces weak or negative growth trends.

Revenue Growth > 5%
4.99%
EPS Growth > 10%
-1.22%

Financial Health Score

Weak

AIMD carries high financial risk with limited liquidity.

Debt/Equity < 1
4.21
Current Ratio > 1
0.13

Profitability Score

Weak

AIMD struggles to sustain strong margins.

ROE > 15%
-217.50%
Net Margin ≥ 15%
-1062.83%
Positive Free Cash Flow
No

Key Financial Metrics

Is AIMD Expensive or Cheap?

P/E Ratio

AIMD trades at -0.18 times earnings. This suggests potential undervaluation.

-0.18

PEG Ratio

When adjusting for growth, AIMD's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Ainos, Inc. at 1.02 times its book value. This may indicate undervaluation.

1.02

EV/EBITDA

Enterprise value stands at 1.01 times EBITDA. This is generally considered low.

1.01

How Well Does AIMD Make Money?

Net Profit Margin

For every $100 in sales, Ainos, Inc. keeps $-1062.83 as profit after all expenses.

-1062.83%

Operating Margin

Core operations generate -1012.10 in profit for every $100 in revenue, before interest and taxes.

-1012.10%

ROE

Management delivers $-2.17 in profit for every $100 of shareholder equity.

-2.17%

ROA

Ainos, Inc. generates $-73.89 in profit for every $100 in assets, demonstrating efficient asset deployment.

-73.89%

Following the Money - Real Cash Generation

Operating Cash Flow

Ainos, Inc. generates limited operating cash flow of $-4.49M, signaling weaker underlying cash strength.

$-4.49M

Free Cash Flow

Ainos, Inc. generates weak or negative free cash flow of $-4.51M, restricting financial flexibility.

$-4.51M

FCF Per Share

Each share generates $-0.61 in free cash annually.

$-0.61

FCF Yield

AIMD converts -1.32% of its market value into free cash.

-1.32%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.18

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.02

vs 25 benchmark

P/S Ratio

Price to sales ratio

246.77

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

4.21

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-2.17

vs 25 benchmark

ROA

Return on assets percentage

-0.74

vs 25 benchmark

ROCE

Return on capital employed

-4.19

vs 25 benchmark

How AIMD Stacks Against Its Sector Peers

MetricAIMD ValueSector AveragePerformance
P/E Ratio-0.1831.66 Better (Cheaper)
ROE-217.50%501.00% Weak
Net Margin-106283.32%-3647.00% (disorted) Weak
Debt/Equity4.21-0.30 (disorted) Distorted
Current Ratio0.135.78 Weak Liquidity
ROA-73.89%-262.00% (disorted) Weak

AIMD outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ainos, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-4.68%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-29.48%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-17.47%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ